We are interested in hepatocarcinogenesis and its potential translation for development of either novel targeted therapies or predictive markers for therapeutic efficacy and/or patient prognosis.34 In this paper, we report the role of M2-type of TAMs in hepatoma resistance to sorafenib by secreting hepatocyte growth factor (HGF). The gene discussed is HGF; the disease is hepatocellular carcinoma.